Cite
Stavraka C, Pouptsis A, Synowiec A, et al. Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors. Clin Colorectal Cancer. 2021;doi: 10.1016/j.clcc.2021.09.009.
Stavraka, C., Pouptsis, A., Synowiec, A., Angelis, V., Satterthwaite, L., Khan, S., Chauhan, M., Holden, C., Young, S., Karampera, C., Martinou, M., Mills-Baldock, T., Baxter, M., Barry, A., Eccles, B., Iveson, T., Shiu, K. K., Hill, M., Abdel-Raouf, S., Graham, J. S., Thomas, A., & Ross, P. J. (2021). Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors. Clinical colorectal cancer, . https://doi.org/10.1016/j.clcc.2021.09.009
Stavraka, Chara, et al. "Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors." Clinical colorectal cancer vol. (2021). doi: https://doi.org/10.1016/j.clcc.2021.09.009
Stavraka C, Pouptsis A, Synowiec A, Angelis V, Satterthwaite L, Khan S, Chauhan M, Holden C, Young S, Karampera C, Martinou M, Mills-Baldock T, Baxter M, Barry A, Eccles B, Iveson T, Shiu KK, Hill M, Abdel-Raouf S, Graham JS, Thomas A, Ross PJ. Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors. Clin Colorectal Cancer. 2021 Sep 26; doi: 10.1016/j.clcc.2021.09.009. Epub 2021 Sep 26. PMID: 34696965.
Copy
Download .nbib